These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3932166)

  • 21. [Different courses of Waldenström's macroglobulinemia].
    Braun HJ; Bruchhaus KF; Aly FW
    Verh Dtsch Ges Inn Med; 1973; 79():345-8. PubMed ID: 4208217
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anti-smooth-muscle antibody activity of monoclonal IgM in Waldenström's disease].
    Krulik M; Vittecoq D; Abuaf N; Genot JY; Homberg JC; Debray J
    Sem Hop; 1983 Jun; 59(23):1737-41. PubMed ID: 6308799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Waldenstrom's macroglobulinemia].
    Geller LI
    Probl Gematol Pereliv Krovi; 1969 Feb; 14(2):40-9. PubMed ID: 4981803
    [No Abstract]   [Full Text] [Related]  

  • 24. Waldenström's macroglobulinemia revealed by atypical blood lymphoid cells.
    Andrieu V; Launay O; Grange MJ
    Haematologica; 1999 Sep; 84(9):858. PubMed ID: 10477462
    [No Abstract]   [Full Text] [Related]  

  • 25. A review of Waldenstrom's macroglobulinemia.
    McDermott MK; Bell EM
    Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated recognition of B and T lymphocytes by immunoperoxidase on the hemalog D system and its applications.
    Dighiero G; Mayzner R; Roisin JP; Binet JL
    Blood Cells; 1982; 8(2):447-54. PubMed ID: 6819019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of monoclonal macroglobulinemia].
    Leporrier M
    Rev Prat; 1993 Feb; 43(3):298-301. PubMed ID: 8502959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Waldenström's macroglobulinemia].
    Brouet JC
    Rev Prat; 2006 Jan; 56(1):25-30. PubMed ID: 16548246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two monoclonal antibodies (OKIa1 and OKT10) for the study of the final B cell maturation.
    Van Camp B; Thielemans C; Dehou MF; De Mey J; De Waele M
    J Clin Immunol; 1982 Jul; 2(3 Suppl):67S-74S. PubMed ID: 6813349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
    Amin CJ; Rabinowitz I
    Clin Lab Haematol; 2005 Jun; 27(3):200-2. PubMed ID: 15938727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macular skin lesion and monoclonal lymphoplasmacytoid infiltrates. Occurrence in primary Waldenström's macroglobulinemia.
    Mozzanica N; Finzi AF; Facchetti G; Villa ML
    Arch Dermatol; 1984 Jun; 120(6):778-81. PubMed ID: 6426407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Waldenström's macroglobulinemia in a 10-year stable IgG monoclonal gammopathy of undetermined significance.
    Iwanaga M; Yoshida Y; Tagawa M; Sekine I; Kamihira S; Tomonaga M
    Leuk Res; 2009 Jan; 33(1):193-5. PubMed ID: 18455789
    [No Abstract]   [Full Text] [Related]  

  • 33. IgM heavy chain fragments in Waldenström's macroglobulinemia.
    Bhoopalam N; Lee BM; Yakulis VJ; Heller P
    Arch Intern Med; 1971 Sep; 128(3):437-40. PubMed ID: 4999186
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-grade MALT lymphoma mimicking Waldenström's macroglobulinemia.
    Allez M; Mariette X; Linares G; Bertheau P; Jian R; Brouet JC
    Leukemia; 1999 Mar; 13(3):484-5. PubMed ID: 10086741
    [No Abstract]   [Full Text] [Related]  

  • 36. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
    Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Waldenström's macroglobulinemia: prognostic factors and recent therapeutic advances.
    Leblond V; Tournilhac O; Morel P
    Clin Exp Med; 2004 Apr; 3(4):187-98. PubMed ID: 15103509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case of mononeuritis multiplex onset with rituximab therapy for Waldenström's macroglobulinemia.
    Mauermann ML; Ryan ML; Moon JS; Klein CJ
    J Neurol Sci; 2007 Sep; 260(1-2):240-3. PubMed ID: 17537458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Waldenstrom's macroglobulinemia].
    Sáenz de Santa María J; Bueno Jiménez C; Elduayen Izaguerri R; Díaz Rodríguez E; Fernández-Cavada Caloca JP; Brull Sabate JM; Pérez Miranda M
    Rev Clin Esp; 1984 Jan; 172(1):1-3. PubMed ID: 6424186
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
    Pangalis GA; Kyrtsonis MC; Kontopidou FN; Vassilakopoulos TP; Siakantaris MP; Dimopoulou MN; Kittas C; Angelopoulou MK
    Semin Oncol; 2003 Apr; 30(2):201-5. PubMed ID: 12720136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.